MedTrace Logo

C2 Esophageal Squamous Epithelium Dysplasia

NCT05349240 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2025-01-13

No results posted yet for this study

Summary

This study will evaluate the efficacy and safety of C2 CryoBalloonTM Ablation System for the cryoablation of dysplastic squamous tissue in patients with moderate to severe esophageal squamous epithelium dysplasia.

Conditions

  • Esophageal Squamous Epithelium Dysplasia

Interventions

DEVICE

C2 CryoBalloonTM Ablation System.

Cryoablation is used to ablate the tissue under the cryogenic condition. The device is mainly used to destroy the unhealthy tissues.

Sponsors & Collaborators

  • Pentax Medical

    lead INDUSTRY

Principal Investigators

  • Guiqi Wang, MD · Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-18
Primary Completion
2025-03-30
Completion
2026-07-31
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05349240 on ClinicalTrials.gov